Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Childhood Solid Tumors × pegfilgrastim × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1 Malignant Solid Tumors 1 Childhood Solid Tumors 1

Interventions

talazoparib 1 pegfilgrastim 1 Temozolomide 1 Irinotecan 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02392793 2021-02-09

Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies

St. Jude Children's Research Hospital

Phase 1 Completed

Other solid neoplasm

Childhood Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡